Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05563051 · ClinicalTrials.gov registry record · NA
Kaneka Endovascular Embolization and Protection
A NA study of Aneurysm Cerebral, sponsored by Kaneka Medical America.
- Active
- Registry status
- NA
- Development phase
- 164
- Enrollment target
- 4
- Study locations
NCT05563051 is a NA study of Aneurysm Cerebral that is active but no longer recruiting, run by Kaneka Medical America. The registered enrollment target is 164 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT05563051, a NA study of Aneurysm Cerebral, is active but no longer recruiting, sponsored by Kaneka Medical America.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
- 4
- Study locations
Study Summary
Prospective, multi-center, non-randomized registry / study, up to 164 patients enrolled and followed at 180 days +/- 45 days and again at 365 days +/- 90 days post procedure
Conditions Studied
Interventions
- DEVICE i-ED COIL
Study Locations (4)
Michigan
- McLaren Health Care - Grand Blanc
New York
- Northwell Health Lenox Hill Hospital - New York
Ohio
- Cleveland Clinic - Cleveland
Oklahoma
- SSM Health St. Anthony's Hospital - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2022-12-13 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05563051
The ClinicalTrials.gov registry entry for NCT05563051 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaneka Medical America, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aneurysm Cerebral appearing as the primary indexed condition, and to 1 intervention - of which i-ED COIL is the first listed.
NCT05563051 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Michigan, New York, Ohio.
Frequently Asked Questions
What is clinical trial NCT05563051 about?
NCT05563051 is a clinical study titled "Kaneka Endovascular Embolization and Protection". Prospective, multi-center, non-randomized registry / study, up to 164 patients enrolled and followed at 180 days +/- 45 days and again at 365 days +/- 90 days post procedure
What is the current status of trial NCT05563051?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 164 participants. The study started on 2022-12-13. Estimated completion is 2025-12.
What conditions does trial NCT05563051 study?
This clinical trial studies the following conditions: Aneurysm Cerebral.
What interventions are being tested in trial NCT05563051?
The interventions under investigation include: i-ED COIL (DEVICE).
Who is sponsoring clinical trial NCT05563051?
This trial is sponsored by Kaneka Medical America, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05563051 being conducted?
This trial has 4 study locations across Michigan, New York, Ohio, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aneurysm Cerebral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.